Showing 1,141 - 1,160 results of 12,750 for search '"therapeutics"', query time: 0.08s Refine Results
  1. 1141

    Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway by Laura Giannotti, Benedetta Di Chiara Stanca, Francesco Spedicato, Daniele Vergara, Eleonora Stanca, Fabrizio Damiano, Luisa Siculella

    Published 2024-12-01
    “…Cannabinoids include both endogenous endocannabinoids and exogenous phytocannabinoids, such as cannabidiol (CBD), and have potential as therapeutic agents in cancer treatment due to their selective anticancer activities. …”
    Get full text
    Article
  2. 1142
  3. 1143
  4. 1144

    Research on therapeutic clinical trials including immunotherapy in triple-negative breast cancer: a bibliometric analysis by Qi Xu, Xiaoyu Feng, Siyuan Qin, Yu Hong, Rui Cui, Jia Liang, Zhuya Xiao, Yuan Li

    Published 2024-10-01
    “…Clinical trial is an important tool for optimizing therapeutic strategies in the evaluation of the safety and efficacy for TNBC. …”
    Get full text
    Article
  5. 1145
  6. 1146

    Molecular characterization of mixed-histology endometrial carcinoma provides prognostic and therapeutic value over morphologic findings by Paulina J. Haight, Ashwini Esnakula, Courtney J. Riedinger, Adrian A. Suarez, Jessica Gillespie, Ashley Patton, Alexis Chassen, David E. Cohn, Casey M. Cosgrove

    Published 2025-02-01
    “…While p53abnl and NSMP tumors have similarly poor outcomes, transcriptome analysis revealed biologic differences that could impact targeted therapeutics in this high-risk group.…”
    Get full text
    Article
  7. 1147

    Genetic insights into therapeutic targets for gout: evidence from a multi-omics mendelian randomization study by Mingyuan Fan, Zhangjun Yun, Jiushu Yuan, Sai Zhang, Hongyan Xie, Dingyi Lu, Haipo Yuan, Hong Gao

    Published 2024-12-01
    “…Summary data-based Mendelian randomization (SMR) analyses based on transcript and protein levels were further implemented to validate the reliability of the identified potential therapeutic targets for gout. Phenome-wide MR (Phe-MR) analysis was conducted in 1403 diseases to investigate incidental side effects of potential therapeutic targets for gout. …”
    Get full text
    Article
  8. 1148
  9. 1149

    Therapeutic dose prediction using score-based diffusion model for pretreatment patient-specific quality assurance by Xiuwen Yu, Jiabin Lin, Changfei Gong, Minhui Zhang, Xianyu Luo, Qiegen Liu, Yun Zhang

    Published 2025-01-01
    “…In the context of this work, the limitation of traditional supervised models was broken by proposing a conditional generation method utilizing unsupervised diffusion model.MethodsA conditional generation method base on the score-based diffusion model was proposed, which employed diffusion model for the first time to predict the predict patients’ therapeutic doses (TherapDose). The proposed diffusion model TherapDose prediction method (DMTP) learns the data distribution of dose images. …”
    Get full text
    Article
  10. 1150
  11. 1151
  12. 1152

    Ultrasound stimulated perfluorobutane microbubbles cavitation enhanced the therapeutic effect of colchicine in rats with acute gouty arthritis by Ji-cheng Zhang, Bo Gou, Tian-rui Wang, Wan-tai Dang, Yan-hui Li, Wen Wen, Jian Liu

    Published 2025-01-01
    “…Objective: This study aimed to explore whether cavitation generated by ultrasound-stimulated microbubbles (USMB) can enhance the therapeutic efficacy of colchicine and diminish its gastrointestinal side effects in rats with acute gouty arthritis (AGA). …”
    Get full text
    Article
  13. 1153
  14. 1154

    Emetophobia (specific phobia of vomiting): Its Relationship with Anxiety-related Disorders and Cognitive Behavioral Therapeutic Approach by Vahdet Gormez, Yavuz Meral, Abdurrahman Cahid Orengul

    Published 2017-04-01
    “…In this article, a phenomenological, epidemiologic and clinical picture of emetophobia is presented and the cognitive behavioral model is discussed as a therapeutic approach for its treatment [JCBPR 2017; 6(1.000): 39-48]…”
    Get full text
    Article
  15. 1155

    Robert's Uterus Versus Juvenile Cystic Adenomyoma – Diagnostic and Therapeutic Challenges – Case Report and Review of Literature by Reeta Mahey, Rohitha Cheluvaraju, Supriya Kumari, Garima Kachhawa, Archana Kumari, Monika Rajput, Neerja Bhatla

    Published 2023-01-01
    “…This case report highlights the diagnostic dilemma and therapeutic challenges encountered while managing adolescent girls with progressive dysmenorrhoea and management of Robert's uterus. …”
    Get full text
    Article
  16. 1156
  17. 1157

    The Diagnostic and Therapeutic Challenges of Posttraumatic Iris Implantation Cysts: Illustrative Case Presentations and a Review of the Literature by Nandini Venkateswaran, Steven S. T. Ching, William Fischer, Frank Lee, Gabrielle Yeaney, Holly B. Hindman

    Published 2015-01-01
    “…Iris implantation cysts can present clinicians with diagnostic and therapeutic challenges given their variable presentations and frequently destructive nature. …”
    Get full text
    Article
  18. 1158

    Plant protein-derived anti-breast cancer peptides: sources, therapeutic approaches, mechanisms, and nanoparticle design by Deju Zhang, Deju Zhang, Deju Zhang, Ying Yuan, Ying Yuan, Qingdong Zeng, Qingdong Zeng, Juan Xiong, Juan Xiong, Yiming Gan, Kai Jiang, Kai Jiang, Ni Xie

    Published 2025-01-01
    “…Consequently, there is an urgent need for low-cost, low-toxicity and effective therapeutic methods to prevent or mitigate breast cancer progression. …”
    Get full text
    Article
  19. 1159

    Therapeutic effect of low-dose BMSCs-Loaded 3D microscaffold on early osteonecrosis of the femoral head by Minzheng Guo, Baochuang Qi, Zijie Pei, Haonan Ni, Junxiao Ren, Huan Luo, Hongxin Shi, Chen Meng, Yang Yu, Zhifang Tang, Yongqing Xu, Qingyun Xue, Chuan Li

    Published 2025-02-01
    “…Results showed that the 3D microscaffold with low-dose BMSCs had a therapeutic effect comparable to high-dose free BMSCs. …”
    Get full text
    Article
  20. 1160